[1] [1] UHLENHOPP D J, THEN E O, SUNKARA T, et al. Epidemiol- ogy of esophageal cancer: update in global trends, etiology and risk factors［J］. Clinical Journal of Gastroenterology, 2020, 13(6): 1010-1021.

[2] [2] HUANG F L, YU S J. Esophageal cancer: risk factors, genetic association, and treatment［J］. Asian Journal of Surgery, 2018, 41(3): 210-215.

[3] [3] ZHENG Yuling , CHEN Yulong. Review on the treatment of esophageal cancer by traditional Chinese medicine［J］. Journal of Traditional Chinese Medicine Oncology, 2020, 2(3): 1-4.

[4] [4] HUANG J , YANG J , ZOU X , et al. Ginkgolide B promotes oligodendrocyte precursor cell differentiation and survival via Akt/CREB/bcl-2 signaling pathway after white matter lesion［J］. Experimental Biology and Medicine (Maywood), 2021, 246( 10): 1198-1209.

[5] [5] KAWASAKI K, KASAMATSU A, ANDO T, et al. Ginkgolide B regulates CDDP chemoresistance in oral cancer via the platelet- activating factor receptor pathway［J］. Cancers (Basel), 2021, 13(24): 6299.

[6] [6] LI Yajing, ZHANG Jie. Effects of ginkgolide B on proliferation and apoptosis of lung cancer cells［J］. Chinese Journal of Hospital Pharmacy, 2021, 41(4): 342-347.

[7] [7] PARK S Y, LEE C J, CHOI J H, et al. The JAK2/STAT3/CCND2 axis promotes colorectal cancer stem cell persistence and radiore- sistance［J］. Journal of Experimental & Clinical Cancer Research, 2019, 38( 1): 399.

[9] [9] JIN Cailing, ZHAO Shupeng, JI Yinghua, et al. Effects of ginkgolide B on proliferation, migration, invasion and apoptosis of lung cancer cell A549 through MMP9/STAT3 signaling pathway［J］. Information ofTraditional Chinese Medicine, 2022, 39( 1): 19-23, 28.

[10] [10] ZANG Chunbao, WAN Yue, WANG Yong, et al. Effects ofAG490 on proliferation, apoptosis and radiotherapy sensitivity of Eca-109 cells in esophageal squamous cell carcinoma［J］. Journal of the Third Military Medical University, 2013, 35( 13): 1357-1361.

[11] [11] PENG Wen, FAN Changling, ZHANG Hao. Effects of LncRNA BCAR4 regulating JAK2/STAT3 signaling pathway on invasion, migration , inflammation and apoptosis of esophageal cancer cells［J］. Journal of Guangxi Medical University, 2020, 37( 12): 2095-2102.

[12] [12] TAN Chang, LU Weimin, XU Danhua, et al. Xu Jingfan’s experi- ence in the treatment of esophageal cancer after operation with“six tone method ”［J］. Journal of Traditional Chinese Medicine, 2019, 60(3): 195-198.

[13] [13] HAN Chenyan, DONG Yun, DOU Shuangting, et al. Effects of systematic traditional Chinese medicine chemotherapy exercise on digestive tract reaction and quality of life in patients with esopha- geal cancer after chemotherapy［J］. Guangxi Medical Journal, 2023, 45(2): 147-151.

[14] [14] WANG X, SHAO Q H, ZHOU H, et al. Ginkgolide B inhibits lung cancer cells promotion via beclin-1-dependent autophagy［J］. BMC Complementary Medicine and Therapies, 2020, 20( 1): 194.

[15] [15] LOU C , LU H , MA Z , et al. Ginkgolide B enhances gem - citabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway［J］. Biomedicine & Pharmacotherapy, 2019, 109: 563-572.

[16] [16] GAO Yuanxi, ZHANG Wei, WANG Yuxia, et al. PTEN overex- pression mediated by ophiotenol enhances the chemical sensitivity of cisplatin to esophageal cancer cells and inhibits tumor formation in nude mice［J］. Journal of Laboratory Animal Science, 2020, 37(6): 22-29.

[17] [17] MONTALTO F I, DE AMICIS F. Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma［J］. Cells, 2020, 9( 12): 2648.

[18] [18] YADAV P, YADAV R, JAIN S, et al. Caspase-3: a primary tar- get for natural and synthetic compounds for cancer therapy［J］. Chemical Biology & Drug Design, 2021, 98( 1): 144-165.

[19] [19] FAN X, FU H, XIE N, et al. Inhibition of JAK2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer ［J］. Aging (Albany NY), 2021, 13( 19): 22830-22842.

[20] [20] YANG G, SHENG B, LI R, et al. Dehydrocostus lactone induces apoptosis and cell cycle arrest through regulation of JAK2/STAT3/ PLK1 signaling pathway in human esophageal squamous cell carcinoma cells［J］. Anti-cancer Agents In Medicinal Chemistry, 2022, 22(9): 1742-1752.